ArticleOncotarget2017
pSY153-MDR, a p12969-DIM-related mega plasmid carrying
Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 22 citations in OpenAlex.
- Emergence of tet(X6) and blaBMC microbiology · 2026Article
- Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2025Review
- Article
- Characteristics and phylogenetic distribution of megaplasmids and prediction of a putative chromid inComputational and structural biotechnology journal · 2024Article
- Characterization of two novel VIM-type metallo-β-lactamases, VIM-84 and VIM-85, associated with the spread of IncP-2 megaplasmids inMicrobiology spectrum · 2023Article
- Phenotypic and genomic characterization ofMicrobial genomics · 2023Article
- Versatility ofHeliyon · 2023Review
- Characterization of a Conjugative Multidrug Resistance IncP-2 Megaplasmid, pPAG5, from a Clinical Pseudomonas aeruginosa Isolate.Microbiology spectrum · 2022Article
- An IncP-2 plasmid sublineage associated with dissemination ofEmerging microbes & infections · 2021Article
- Epidemic Territorial Spread of IncP-2-Type VIM-2 Carbapenemase-Encoding Megaplasmids in Nosocomial Pseudomonas aeruginosa Populations.Antimicrobial agents and chemotherapy · 2021Article
- Long-term Persistence of an Extensively Drug-Resistant Subclade of Globally Distributed Pseudomonas aeruginosa Clonal Complex 446 in an Academic Medical Center.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020Article
- A megaplasmid family driving dissemination of multidrug resistance in Pseudomonas.Nature communications · 2020Article
- Article
- Not all Pseudomonas aeruginosa are equal: strains from industrial sources possess uniquely large multireplicon genomes.Microbial genomics · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This work characterized mega plasmid pSY153-MDR, carrying
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.